Louise Goksøyr

Company: AdaptVac

Job title: Project Lead & Scientist

Seminars:

A Capsid Virus-like Particle Based Vaccine Displaying IL-11 for Treatment of Fibrotic Diseases 11:00 am

Leveraging AdaptVac’s virus-like particles-based vaccine platform with proven safety in clinical trials, to display self-antigens for the induction of autoreactive antibodies for the treatment of chronic diseases. Showing proof of mechanism for an IL11 targeting vaccine in overcoming immune tolerance in mice and guinea pigs Demonstrating proof of concept in a MASH guinea pig model,…Read more

day: Conference Day Two